Biomaterials for use in frontal sinus obliteration

Journal of Long-Term Effects of Medical Implants

Volumn 14, Issue 6, 2004, Pages 455-465

  D'Addario, Matthew ^a   Haug, Richard H ^a   Talwar, Reena M ^a  

^a UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

Author keywords

Abdominal fat; Bone; Glass ionomer; Hydroxyapatite bone cement; Hydroxyapatite crystals

Indexed keywords

ALLOPLASTIC MATERIALS; FRONTAL SINUS; OBLITERATION;

BRAIN; DUCTS; PATIENT TREATMENT;

BIOMATERIALS;

BIOMATERIAL; BONE CEMENT; CALCIUM PHOSPHATE; FAT; GLASS IONOMER; HYDROXYAPATITE;

ALLOGRAFT; AUTOGRAFT; BONE; BRAIN; CONSENSUS; EYE; FACE INJURY; FOREIGN BODY REACTION; FRACTURE; FRONTAL SINUS OBLITERATION; GRAFT REJECTION; IMMOBILIZATION; IMPLANT; JAW MOVEMENT; MORBIDITY; MUSCLE; NONHUMAN; POSTOPERATIVE COMPLICATION; REVIEW; SURGICAL INFECTION; TEMPORALIS MUSCLE; TRISMUS;

ADIPOSE TISSUE; BIOCOMPATIBLE MATERIALS; BIOPROSTHESIS; BONE SUBSTITUTES; FRACTURE FIXATION; FRACTURE HEALING; FRONTAL SINUS; HUMANS; OSTEOGENESIS; PROGNOSIS; RISK ASSESSMENT; SKULL FRACTURES; TRANSPLANTATION, AUTOLOGOUS;

EID: 11244249682     PISSN: 10506934     EISSN: None     Source Type: Journal    
DOI: 10.1615/JLongTermEffMedImplants.v14.i6.30     Document Type: Review

References (75)

1. Haug RH, Cunningham LL. Management of Fractures of the Frontal Bone and Frontal Sinus. Selected Readings in Oral Maxillofac Surg 2002; 10(1):1-32.
2. Schultz RC. Supraorbital glabellar fractures. Plast Reconstr Surg 1970; 45(3):227-233.
3. Onishi K, Nakajima T, Yoshimura Y. Treatment and therapeutic devices in the management of frontal sinus fractures. Our experience with 42 cases. J Craniomaxillofac Surg 1989; 17(2):58-63.
4. Xie C, Mehendale N, Barrett D, Bui CJ, Metzinger SE. 30-year retrospective review of frontal sinus fractures: the Charity Hospital experience. J Cranio-Maxillofac Trauma 2000; 6(1):7-16.
5. McHugh HE. Treatment of fractures of the frontal and ethmoid sinuses. Laryngoscope 1958; 68(9):1616-1640.
6. May M, Ogura JH, Schramm V. Nasofrontal duct in frontal sinus fractures. Arch Otolaryngol 1970; 92(6):534-538.
7. Haug RH, Cunningham LL, Brandt TM. Plates, screws and children: their relationships in craniomaxillomaxillofacial trauma. J Long Term Eff Med Implants 2003; 13(4):271-287.
8. Lawson W. Frontal sinus. In: Blitzer A, Lawson W, Friedman W, editors. Surgery of the Paranasal Sinuses. Philadelphia, PA: WB Saunders 1985.
9. Davis BR, Sandor GK. Use of fibrin glue in maxillofacial surgery. J Otolaryngol 1998; 27(2):107-12.
10. Siedentop KH, Park JJ, Shah AN, Bhattacharyya TK, O'Grady KM. Safety and efficacy of currently available fibrin tissue adhesives. Am J Otolaryngol 2001; 22(4):230-235.
11. Al Yamany M, Del Maestro RF. Prevention of subdural fluid collection following transcortical intraventricular and/or paraventricular procedures by using fibrin adhesive. J Neurosurg 2000; 92(3):406-412.
12. Man D, Plosker H, Winland Brown JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 2001; 107(1):229-237.
13. Stover EP, Siegel LC, Hood PA, O'Riordan GE, McKenna TR. Platelet-rich plasma sequestration, with therapeutic platelet yields, reduces allogeneic transfusion in complex cardiac surgery. Anesth Analg 2000; 90(3):509-516.
14. Kheirabadi BS, Pearson R, Tuthill D, Rudnicka K, Holcomb JB, Drohan W, MacPhee MJ. Comparative study of the hemostatic efficacy of a new human fibrin sealant: is an antifibrinolytic agent necessary? J Trauma 2002; 52(6):1107-1115.
15. Urken ML, Som PM, Lawson W, Edelstein D, McAvay G, Biller HF. The abnormally large frontal sinus. I. A practical method for its determination based upon an analysis of 100 normal patients. Laryngoscope 1987; 97(5):603-605.
16. Sanchez Fernandez JM, Escuredo JA, Sanchez Del Rey A, Santaolalla MF. Morphometric study of the paranasal sinuses in normal and pathological conditions. Acta Otolaryngol 2000; 120(2):273-278.
17. Ponde JM, Metzger P, Amaral G, Machado M, Prandini M. Anatomic variations of the frontal sinus. Minim Invasive Neurosurg 2003; 46(1):29-32.
18. Barghouth G, Prior JO, Lepori D, Duvoisin V, Schnyder P, Gudinchet F. Paranasal sinuses in children: size evaluation of maxillary, sphenoid, and frontal sinuses by magnetic resonance imaging and proposal of volume index percentile curves. Eur Radiol 2002; 12(6):1451-1458.
19. Samoilenko A. Obliteration post-operatoire de sinus frontaux. Arch Int Laryngol 1913; 35:337.
20. Hybels RL. Posterior table fractures of the frontal sinus. II. Clinical aspects. Laryngoscope 1977; 87(2):1740-1745.
21. Abramson AA, Eason RL. Experimental frontal sinus obliteration: Long-term results following removal of the mucous membrane lining. Laryngoscope 1977; 87(8):1066-1073.
22. Mickel TJ, Rohrich RJ, Robinson JB. Frontal sinus obliteration: a comparison of fat, bone, muscle and spontaneous osteogenesis in the cat model. Plast reconst Surg 1990; 95(3):586-592.
23. Newman MH, Travis LW. Frontal sinus fractures. Laryngoscope 1973; 83(8):1281.
24. Nadell J, Kline DG. Primary reconstruction of depressed frontal skull fractures including those involving the sinus and cribriform plate. J Neurosurg 1974; 41(2):200-247.
25. Wallis A, Donald PJ. Frontal sinus fracture: a review of 72 cases. Laryngoscope 1988; 98(6 Pt 1):593-598.
26. Knauf HA. A single-staged frontal sinus obliteration. Arch Otolaryngol 1963; 78(3):707.
27. Dickenson JT, Capic JA, Kameron DB. Principles of frontal reconstruction. Laryngoscope 1969; 79(6):1019-1075.
28. Rohrich RJ, Mickel TJ. Frontal sinus obliteration: in search of the ideal material. Plast Reconst Surg 1995; 95(3):580-585.
29. McNulty JS. Frontal sinus reconstruction with bone or cartilage grafts. Ear Nose Throat 1986; 65(11):512-516.
30. Sataloff RT, Sariego J, Meyers DL, Richter HJ. Surgical management of the frontal sinus. Neurosurgery 1984; 15(4):593-596.
31. Wilson BC, Davidson B, Corey JP, Haydon RC 3rd. Comparison of complications following frontal sinus fractures managed with exploration with or without obliteration over 10 years. Laryngoscope 1998; 98(5):516-520.
32. Goodale RL. The rationale for frontal sinus surgery. Laryngoscope 1965; 75:981-987.
33. Valenza C. Treatment of traumatic disease of the frontal sinus by obliteration. Laryngoscope 1967; 77(9).
34. Goodale RL, Montgomery WW. Technical advances in osteoplastic frontal sinusotomy. Arch Otolaryngol 1964; 79:522-529.
35. Failla A. Operative management of injuries involving the frontal sinus. Laryngoscope 1968; 78(11):183-1852.
36. Sessions RB, Alford BR, Stratton C, Ainsworth JZ, Shill O. Current concepts of frontal sinus surgery: an appraisal of the osteoplastic flap-fat obliteration operation. Laryngoscope 1972; 82(5):918-930.
37. Denneny JC. Frontal sinus obliteration using liposuction. Otolaryngol Head Neck Surg 1986; 95(1):15-18.
38. Petruzzelli GJ, Stankiewicz JA. Frontal sinus obliteration with hydroxyapatite cement. Laryngoscope 2002; 112(1):32-6.
39. Goodale RL. Obliteration of the frontal sinus. Ann Otolaryngol Rhin Laryngol 1965; 74(3):831-840.
40. Sessions RB, Alford BR, Straton C, Ainsworth JZ, Shill O. Current concepts of frontal sinus surgery: an appraisal of the osteoplastic flap-fat obliteration operation. Laryngoscope 1972; 82(5):918-930.
41. Schenck NL, Tomlinson MJ, Ridgley CD. Experimental evaluation of a new implant material in frontal sinus obliteration. Arch Otolaryngol 1976; 102(9):524-528.
42. Manson PN, Crawley WA, Hoopes JE. Frontal cranioplasty: risk factors and choice in cranial vault reconstructive material. Plast Reconstr Surg 1986; 77(6):888-904.
43. Jarcho M. Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop 1981; 157:259-278.
44. Kent JN, Zide MF, Kay JF, Jarcho M. Hydroxyapatite blocks and particles as bone graft substitutes in orthognathic and reconstructive surgery. J Oral Maxillofac Surg 1986; 44(8):487-605.
45. Holmes RE. Bone regeneration within a coralline hydroxyapatite implant. Plast Reconstr Surg 1979; 63(5):626-633.
46. Brown WE, Chow LC. A new calcium phosphate, water-setting cement. In: Brown PW, editor. Cements Research Progress. Westerville, Ohio: American Ceramic Society, 1986.
47. Friedman CD, Costantino PD, Jones K, Chow LC, Pelzer HJ Sission GA Sr. Hydroxyapatite cement. II: Obliteration and reconstruction of the cat frontal sinus. Arch Otolaryngol Head Neck Surg 1991; 117(4):385-589.
48. Costantino PD. Synthetic biomaterials in soft tissue augmentation and replacement in the head and neck. Otolaryngol Clin North Am 1994; 27(1):223-262.
49. Chow LC, Takigi S, Constantino PD, Friedman CD. Self-setting calcium phosphate cements. Mater Res Soc Symp Proce 1991; 179:3-24.
50. Costantino PD, Friedman CD, Jones K, Chow LC, Pelzer HJ Sission GA Sr. Hydroxyapatite cement: I. Basic chemistry and histologic properties. Arch Otolaryngol Head Neck Surg 1991; 117(4):379-384.
51. Friedman CD, Costantino PD, Takagi S, Chow LC. BoneSource hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction. J Biomed Mater Res. 1998; 43(4):428-32.
52. Friedman CD, Costantiono PD, Snyderman CH, Chow LC, Takagi S. Reconstruction of the frontal sinus and frontofacial skeleton with Hydroxyapatite cement. Arch Plast Surg 2000; 2(2):124-129.
53. Rosen G, Nachtigal D. The use of Hydroxyapatite for obliteration of the human frontal sinus. Laryngoscope 1995; 105(5 Pt 1):553-555.
54. Petruzzelli GJ, Stankiewicz JA. Frontal sinus obliteration with hydroxyapatite cement. Laryngoscope 2002; 112(1):32-36.
55. Ross D, Marentette LJ, Thompson G, Haller JS. Use of Hydroxyapatite bone cement to prevent cerebrospinal fluid leakage through the frontal sinus. Technical report. Neurosurgery, 2002; 45(2):401-403.
56. Maniker A, Cantrell S, Vaicys C. Failure of hydroxyapatite cement to set in repair of a cranial defect: case report. Neurosurgery 1998; 43(4):953-955.
57. Kveton JF, Friedman CD, Piepmeier JM, Costantino PD. Reconstruction of suboccipital craniectomy defects with hydroxyapatite cement: a preliminary report. Laryngoscope 1995; 105(2):156-159.
58. Dujovny M, Aviles A, Anger C. An innovative approach for cranioplasty using hydroxyapatite cement. Surg Neruol 1997; 48(3):294-297.
59. Frankenburg EP, Goldstein SA, Bauer TW, Harris SA, Poser RD. Biomechanical and histological evaluation of a calcium phosphate cement. J Bone Joint 1998; 80A(8):1112-1124.
60. Baker SB, Weinzweig J, Kirschner RE, Bartlett SP. Applications of a new carbonated calcium phosphate bone cement: early experience in pediatric and adult craniofacial reconstruction. Plast Reconstr Surg 2002; 109(6):1789-179.
61. Clokie CML, Moghadam H, Jackson MT, Sandor GK. Closure of critical sized defects with allogenic and alloplastic bone substitutes. J Craniofac Surg 20021; 3(1):111-121.
62. Kirschner R.E, Karmacharya J, Ong G, Gordon AD, Hunenko O, Losee JE, Gannon FH, Bartlett SP. Repair of the immature craniofacial skeleton with a calcium phosphate cement: quantitative assessment of craniofacial growth. Ann Plast Surg 2002; 49(1):33-38.
63. Mahr MA, Bartley GB, Bite U, Clay RP, Kasperbauer JJ, Holmes JM. Norian craniofacial repair system bone cement for the repair of craniofacial skeletal defects. Ophthal Plast Reconstr Surg 2000; 16(5):393-398.
64. Matic D, Phillips JH. A contraindication for the use of hydroxyapatite cement in the pediatric population. Plast Reconst Surg 2002; 110(1):1-5.
65. Hench LL, Splinter RJ, Allen WC, Greenlee TK Jr. Bonding mechanism at the interface of ceramic prosthetic materials. J Biomed Mater Res Symp 1971; 5:117-141.
66. McClean JW. Glass-ionomer cements. Br Dent J 1988; 164:293-300.
67. Peltola MJ, Suonpää JTK, Aitasalo KMJ, Maattanen H, Andersson O, Yli-Urpo A, Laippala PJ. Experimental follow-up model for clinical frontal sinus obliteration with bioactive glass (S53P4). Acta Otolaryngol Suppl 2000; Suppl 54:167-169.
68. Peltola MJ, Suonpää JTK, Maattanen HS, Varpula MJ, Aitasalo KMJ, Yli-Urpo A, Laippala PJ. Clinical follow-up method for frontal sinus obliteration with bioactive glass S53P4. J Biomed Mater Res 2001; 58(1):54-60.
69. Nagasae M, Abe Y, Chikira M, Udagawa EI. Toxicity of silica containing calcium phosphate glasses demonstrated in mice. Biomater 1992; 13(3):172-175.
70. Wilson J, Pigott GH, Schoen FJ, Hench LL. Toxicology and biocompatibility of bioglasses. J Biomed Mater Res 1981; 15(6):805-881.
71. Peltola MJ, Suonpää JTK, Aitasalo KMJ, Varpula M Yli-Urpo A, Happonen RP. Obliteration of the frontal sinus cavity with bioactive glass. Head Neck 1998; 20(4):315-319.
72. Gross U, Strunz V. The interface of various glasses and glass ceramics with a bony implantation bed. J Biomed Mater Res 1985; 19(3):251-271.
73. Aitasalo K, Suonpää J, Peltola M, et al. Behaviour of bioactive glass (S53P4) in human frontal sinus obliteration. Bioceramics 1997; 10:429-432.
74. Peltola MJ, Aitasalo KMJ, Suonpää JTK, Yli-Urpo A, Laipala PJ, Forsback AP. Frontal sinus and skull bone defect obliteration with three synthetic bioactive materials. A comparative study. J Biomed Mater Res Part B: Appl Biomater 2001; 66B(1):364-372.
75. Peltola MJ, Aitasalo KMJ, Suonpää JTK, Yli-Urpo A, Laippala PJ. In vivo model for frontal sinus and calvarial bone defect obliteration with bioactive glass S53P4 and hydroxyapatite. J Biomed Mater Res 2001; 58(3):261-269.